Influence of antibodies against infliximab and etanercept on the treatment effectiveness of these agents in Japanese patients with rheumatoid arthritis.

MLA

Hoshino, Motoaki, et al. “Influence of Antibodies against Infliximab and Etanercept on the Treatment Effectiveness of These Agents in Japanese Patients with Rheumatoid Arthritis.” Modern Rheumatology, vol. 22, no. 4, Aug. 2012, pp. 532–40. EBSCOhost, https://doi.org/10.1007/s10165-011-0567-8.

APA

Hoshino, M., Yoshio, T., Onishi, S., & Minota, S. (2012). Influence of antibodies against infliximab and etanercept on the treatment effectiveness of these agents in Japanese patients with rheumatoid arthritis. Modern Rheumatology, 22(4), 532–540. https://doi.org/10.1007/s10165-011-0567-8

Chicago

Hoshino, Motoaki, Taku Yoshio, Sachiko Onishi, and Seiji Minota. 2012. “Influence of Antibodies against Infliximab and Etanercept on the Treatment Effectiveness of These Agents in Japanese Patients with Rheumatoid Arthritis.” Modern Rheumatology 22 (4): 532–40. doi:10.1007/s10165-011-0567-8.